Accordingly, following PR there was a significant increase in protein levels of ECM biomarkers (collagen type I by 90 pg·mL−1; collagen type IV by 120 pg·mL−1; decorin by 70 pg·mL−1) only in nonatrophic patients with COPD. The gene discussed is DCN; the disease is chronic obstructive pulmonary disease.